Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
bankruptcy
MedTech
Wojcicki prevails in 23andMe auction, with final $305M bid
Her $305 million offer topped the previous frontrunner, Regeneron, which bid $256 million to incorporate the DNA tester's assets in its R&D.
Conor Hale
Jun 16, 2025 10:40am
Regeneron’s $256M bid wins 23andMe bankruptcy auction
May 19, 2025 10:37am
Anne Wojcicki steps down to bid on 23andMe’s bankruptcy auction
Mar 24, 2025 10:43am
Flagship's Omega sinks toward bankruptcy, lays off staff
Feb 4, 2025 4:59am
New York biotech files for bankruptcy
Nov 22, 2024 10:47am
The 2024 Biotech Graveyard
Oct 31, 2024 5:00am
